Functional studies show that variants from LQTS patients impair calcium binding [1, 16] and affect calmodulin’s ability to regulate the voltage-gated calcium channel 1.2 (CaV1.2) [12, 17–19]. Here, CACNA1C is linked to familial long QT syndrome.